These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36199399)

  • 1. Outcome of type and screen versus crossmatch in cardiovascular surgery patients: A comparative study.
    Pokhrel A; Jain A; Marwaha N; Singh RS
    Asian J Transfus Sci; 2022; 16(1):1-6. PubMed ID: 36199399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.
    Tiwari AK; Aggarwal G; Dara RC; Arora D; Gupta GK; Raina V
    Asian J Transfus Sci; 2017; 11(1):40-44. PubMed ID: 28316439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India.
    Pathak S; Chandrashekhar M; Wankhede GR
    Asian J Transfus Sci; 2011 Jul; 5(2):153-6. PubMed ID: 21897595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch?
    Lee E; Redman M; Burgess G; Win N
    Transfusion; 2007 Jul; 47(7):1290-5. PubMed ID: 17581166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crossmatching technique facilitating kidney transplantation.
    Buabut B; Chiewsilp P; Patanapanyasat K; Jirasiritham S; Mavichak V; Sujirachato K; Mongkolsuk T
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S55-61. PubMed ID: 9347647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between enzyme-linked immunosorbent assay and cytotoxic cross-match procedures for detecting IgG anti-donor antibodies.
    Susskind B; Kerman RH; Nelson R; Gregory J; La T; Bayat A; Dang M; Van Buren C; Katz S; Kahan BD
    Transplantation; 1998 Dec; 66(12):1823-6. PubMed ID: 9884282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of previous erythrocyte alloimmunization and the type and screen at a large cancer center. A 4-year retrospective review.
    Havemann H; Lichtiger B
    Cancer; 1992 Jan; 69(1):252-5. PubMed ID: 1727671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of Luminex-based single antigen class II bead assay and its mean fluorescence intensity in renal transplant cases; a retrospective observation in 97 cases.
    Pande A; Pandey P; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
    J Immunoassay Immunochem; 2020 May; 41(3):322-336. PubMed ID: 32122239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population.
    Mathur A; Jindal A; Tiwari AK; Bhuyan D; Jagannathan L; Sawant RB; Basu S; Reddy M; Datta SS
    Immunohematology; 2022 Sep; 38(3):100-105. PubMed ID: 36190198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term kidney graft survival across a positive historic but negative current sensitized cross-match.
    Baron C; Pastural M; Lang P; Bentabet R; el-Kassar N; Seror T; Dahmane D; Desvaux D; Chopin D; Fruchaud G; Remy P; Grimbert P; Lepage E; Bierling P
    Transplantation; 2002 Jan; 73(2):232-6. PubMed ID: 11821736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
    Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
    J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Gerolami K; Kahan BD
    Transplantation; 1990 Jan; 49(1):52-6. PubMed ID: 2301027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type and screen method and Coombs crossmatch method for pretransfusion testing: A prospective comparative study in a tertiary care hospital in Delhi.
    Anu KD; Pahuja S; Sharma G
    Asian J Transfus Sci; 2022; 16(1):83-88. PubMed ID: 36199420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization.
    Dinardo CL; Bonifácio SL; Mendrone A
    Immunohematology; 2014; 30(1):1-5. PubMed ID: 25238242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA: ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS.
    Ndahimana E; Gothot A; Gérard C; Senyana F; R'Zik S; Mukabayire O; Mutesa L
    East Afr Med J; 2013 Apr; 90(4):124-9. PubMed ID: 26866096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
    Heddle NM; O'Hoski P; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1992 Aug; 81(4):579-84. PubMed ID: 1390245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of naturally occurring alloantibody by an in-clinic antiglobulin-enhanced and standard crossmatch gel column test in non-transfused domestic shorthair cats.
    Goy-Thollot I; Nectoux A; Guidetti M; Chaprier B; Bourgeois S; Boisvineau C; Barthélemy A; Pouzot-Nevoret C; Giger U
    J Vet Intern Med; 2019 Mar; 33(2):588-595. PubMed ID: 30557453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
    Transplantation; 1991 Feb; 51(2):316-20. PubMed ID: 1994522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is type and screen only policy safe for patients undergoing elective lobectomy?
    Devbhandari MP; Farid S; Goatman C; Moussa Y; Rammohan KS; Krysiak P; Jones MT; Shah R
    Eur J Cardiothorac Surg; 2013 Dec; 44(6):1113-6; discussion 116. PubMed ID: 23729754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.